Risk factors associated with oropharyngeal candidiasis in COVID-19 patients: a case control study (vol 60, myac072S11d, 2022)

被引:0
|
作者
Carattoli, A.
机构
关键词
D O I
10.1093/mmy/myac091
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Risk Factors of Oropharyngeal Candidiasis in COVID-19 Patients: A Case-control Study
    Salehi, Mohammadreza
    Khajavirad, Nasim
    Darazam, Ilad Alavi
    Hashemi, Seyed Jamal
    Ansari, Saham
    Ghiasvand, Fereshteh
    Jamalimoghadamsiahkali, Saeidreza
    Izadi, Alireza
    Kiyaei, Reyhaneh Sadat
    Seifi, Arash
    Abolghasemi, Sara
    Hatami, Firouze
    Boekhout, Teun
    Manshadi, Seyed Ali Dehghan
    Khodavaisy, Sadegh
    [J]. ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2021, 16 (05):
  • [2] Risk factors a ssociated with oropharyngeal candidiasis in COVID-19 patients: a casecontrol study
    Salehi, Mohammadreza
    Kiyaei, Reyhaneh Sadat
    Khodavaisy, Sadegh
    Khajavirad, Nasim
    Manshadi, Seyed Ali Dehghan
    Darazam, Ilad Alavi
    Seifi, Arash
    [J]. MEDICAL MYCOLOGY, 2022, 60 (SUPP 1): : 1 - 1
  • [3] Risk factors for COVID-19 associated mucormycosis in India: A case control study
    Patel, Atul K.
    Bakshi, Harsh
    Shah, Kahaan
    Patel, Saloni
    Patel, Tushar
    Patel, Kamlesh
    Patel, Ketan K.
    [J]. MEDICAL MYCOLOGY, 2022, 60 (07)
  • [4] Risk Factors of Pulmonary Complications in Patients with COVID-19: A Case-Control Study
    Eslamian, Mohammad
    Zefreh, Hamidreza
    Sheikhbahaei, Erfan
    Ghasemi, Maryam
    Fasahat, Amirhossein
    Talebzade, Hamid
    Parchami, Koorosh
    Nazemroaya, Behzad
    Tarrahi, Mohammad Javad
    Firoozfar, Alireza
    Esfahanian, Fatemeh
    [J]. ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2024, 19 (02):
  • [5] COVID-19 Associated Mucormycosis and Risk Factors: A Case-Control Study from Turkey
    Toker, Aysin Kilinc
    Ozdemir, Ayse Turunc
    Kanat, Azade
    Eren, Esma Eryilmaz
    Sav, Hafize
    Ozcan, Ibrahim
    Celik, Ilhami
    [J]. JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2024, 17 (04)
  • [6] Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study
    Uranga, A.
    Villanueva, A.
    Lafuente, I
    Gonzalez, N.
    Legarreta, M. J.
    Aguirre, U.
    Espana, P. P.
    Quintana, J. M.
    Garcia-Gutierrez, S.
    [J]. REVISTA CLINICA ESPANOLA, 2022, 222 (01): : 22 - 30
  • [7] The Risk Factors for the Exacerbation of COVID-19 Disease: A Case-control Study
    Fan, Ying
    Wang, Xuefei
    Jun Zhang
    Mo, Daorong
    Xiao, Xuexia
    [J]. JOURNAL OF CLINICAL NURSING, 2021, 30 (5-6) : 725 - 731
  • [8] Risk factors of pneumothorax and pneumomediastinum in COVID-19: a matched case–control study
    Se Ju Lee
    Jinnam Kim
    Ki Hyun Lee
    Jung Ah Lee
    Chang Hyup Kim
    Su Hwan Lee
    Byung Jo Park
    Jung Ho Kim
    Jin Young Ahn
    Su Jin Jeong
    Nam Su Ku
    Joon-Sup Yeom
    Jun Yong Choi
    [J]. BMC Infectious Diseases, 23
  • [9] Risk Factors of COVID-19 associated mucormycosis in Iranian patients: a multicenter study
    Eshraghi, Bahram
    Khademi, Behzad
    Mirmohammadkhani, Majid
    Khataminia, Gholamreza
    Ghahvehchian, Hossein
    Kiarudi, Mohammad Yaser
    Nabie, Reza
    Parandin, Mohammadmehdi
    Ghasemi Boroumand, Paria
    Mohammadi, Rasoul
    Zia, Zahra
    Karamirad, Soroush
    Jafarpour, Soheyla
    Fakoor, Mostafa
    Varshochi, Mojtaba
    Shahraki, Kourosh
    Memarzadeh, Mohammad
    Janipour, Masoud
    Mahdian Rad, Atefe
    Kashkouli, Mohsen B.
    Shekarchian, Farid
    Manouchehri, Vahideh
    Khosravi, Abbas
    Abounoori, Mahdi
    Shahir, Abazar
    Sajjadi, S. Mohammad Javad
    Etezad Razavi, Mohammad
    Hosseini, Nastaran-Sadat
    Ebrahimi, Fatemeh
    Noorshargh, Pegah
    Forouhari, Ali
    Pourazizi, Mohsen
    [J]. BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [10] Case-control study on risk factors for in-hospital mortality in patients with severe COVID-19
    Wu, Kemei
    Yin, Lili
    Han, Jiangqin
    Cai, Qiuhan
    Guo, Yang
    Jin, Xin
    Wu, Jinling
    Cheng, Yupei
    [J]. FRONTIERS IN PUBLIC HEALTH, 2024, 12